Big pharma firm hits back in COVID-19 tech dispute

06-09-2022

Staff Writer

Big pharma firm hits back in COVID-19 tech dispute

Marcus Krauss / Shutterstock.com

CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid


CureVac, BioNTech, patent infringement, COVID-19, mRNA, vaccines, vaccination, messenger ribonucleic acid, Comirnaty

LSIPR